Biopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights)

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This research service provides an emerging technology analysis of biopharmaceutical developments across the globe.

Table of Contents

Biopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Executive SummaryIntroductionIntroduction to BiopharmaceuticalsOverview of the Biopharmaceutical IndustryScope & MethodologyScope and Segmentation of this Research ServiceMethodologyBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Monoclonal Antibody TechnologiesTechnology PrimerAn Overview of Monoclonal AntibodiesApplicationsNoteworthy Innovations at Key Companies; Academic and Government-Related InstitutionsCost-Effective System for Production of Monoclonal Antibodies in YeastAntibody-Vaccine Combination Therapy for MelanomaAbbott’s Fully Human Anti-Il-12 Monoclonal AntibodyMonoclonal Antibody for Autoimmune DiseasesAnti-IL-9 Monoclonal Antibody for Controlling AsthmaInfluential Market FactorsIndustry Trends A Brief on Important Clinical TrialsBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Vaccines and AntigensTechnology Primer An Overview of Vaccines Emerging Applications of VaccinesNoteworthy Innovations at Key Companies; Academic and Government-Related InstitutionsDNA Sequences for Stimulating Immune ResponsesSingle-Dose AIDS Vaccine in Phase I TrialsProstate Cancer Vaccine in Phase III TrialsNovel Cancer Immunotherapy Product for Colorectal CancerInfluential Market FactorsIndustry TrendsA Brief on Important Clinical TrialsBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Tissue EngineeringTechnology Primer OverviewApplicationsNoteworthy Innovations at Key Companies; Academic and Government-Related InstitutionsStem Cell Therapy for Regeneration of MeniscusAdvances in Cloning Create Patient-Specific Stem CellsFeeder-Free Derivation of Embryonic Stem CellsNaturally-Derived Extracellular Matrix Material for Wound ManagementTelomerase Technology for Developing Human Embryonic Stem CellsInfluential Market FactorsIndustry TrendsA Brief on Important Clinical TrialsBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Hormones and EnzymesTechnology Primer Human InsulinsHuman Growth HormonesTissue Plasminogen ActivatorsThyroid Stimulating HormonesFertility HormonesBlood Clotting FactorsRecombinant EnzymesNoteworthy Innovations at Key Companies; Academic and Government-Related InstitutionsRecombinant Enzyme for Dissolving Blood ClotsEnzyme Replacement Therapy for MucopolysaccharidosisNatural Plant Enzyme to be a Potential Candidate for Lung CancerRecombinant Human Thrombin as an Alternative to Bovine-Derived ProductBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Cytokines and Peptide TherapeuticsTechnology Primer Colony Stimulating FactorsInterleukinsInterferonsNoteworthy Innovations at Key Companies; Academic and Government-Related InstitutionsLow Dose Interferon Alpha Provides Effective Treatment for Variety of ConditionsNatural Peptide Promotes Wound HealingDiscovery of Protein Leads to Potential Pathway for Treating Multiple SclerosisRecombinant Natriuretic Peptide for Heart FailureProtein as a Marker and Target for Breast CancerRecombinant Beta Interferon for Multiple SclerosisBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Technology Adoption Factor Analysis and Commercial LandscapeTechnology AnalysisTechnology AcceleratorsTechnology RoadblocksRegulatory TrendsCorporate CollaborationsPart IPart IIBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Database of Key Industry Participants; Selected Patents & GlossaryDatabase of Key Industry ParticipantsCompanies and OrganizationsUniversities and AcademiaSelected Patents & GlossaryImportant Patents IImportant Patents IIBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Frost & Sullivan 2005 Science & Technology AwardsExcellence in TechnologyAward DescriptionAward RecipientExcellence in ResearchAward DescriptionAward RecipientTechnology Innovation AwardAward DescriptionAward RecipientBiopharmaceutical Developments--An Emerging Technology Analysis (Technical Insights), Critical Reference TablesHealthcare ExpenditureGovernment Healthcare ExpenditurePrivate Healthcare ExpenditureBiotech ExpenditureNumber of Biotech Companies (1999-2006)Government Investment in Biotech R&D (1999-2006)Private Investment in Biotech R&D (1999-2006)Number of Biotech PatentsUSPTO Biotech Patents (1996-2000)EPO Biotech Patents (1996-2000)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.